EIDD-2749

Biorbyt

EIDD-2749

10

Research Use Only

97.39%

C9H11FN2O6

262.19

EIDD-2749 (4-FlU), a ribonucleoside analog, is an orally available RdRp inhibitor with spectroscopic antiviral activity that interrupts the replication of respiratory syncytial virus and SARS-CoV-2.EIDD-2749 attenuates lethal infections of pandemic human and highly pathogenic avian influenza viruses.

O[C@H]1[C@@H](O[C@@](CO)(F)[C@H]1O)N2C(=O)NC(=O)C=C2

-20°C

12352200